Amgen Reports First Quarter 2017 Financial Results

View printer-friendly version Amgen Reports First Quarter 2017 Financial Results BUZ INVESTORS  PRESS RELEASE  Amgen Reports First Quarter Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2017. Key results include: Total revenues decreased 1 percent versus the first quarter of 2016 to $5.5 billion. GAAP earnings per share (EPS) increased 12 percent to
Complete Reading

Amgen Stock – the Best Biotech Stock 2017? Buz Investors Best Biotech Stock 2017  The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors. With so much depending on government regulation, competition, and public opinion, there’s a lot of room to make big gains in the biotech industry, and a lot
Complete Reading

Create Account

Log In Your Account